{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:02:54Z","timestamp":1792634574740,"version":"4.5.0"},"reference-count":213,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K08073"],"award-info":[{"award-number":["19K08073"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Although a number of mood-stabilising atypical antipsychotics and antidepressants modulate serotonin type 7 receptor (5-HT7), the detailed contributions of 5-HT7 function to clinical efficacy and pathophysiology have not been fully understood. The mood-stabilising antipsychotic agent, lurasidone, and the serotonin partial agonist reuptake inhibitor, vortioxetine, exhibit higher binding affinity to 5-HT7 than other conventional antipsychotics and antidepressants. To date, the initially expected rapid onset of antidepressant effects\u2014in comparison with conventional antidepressants or mood-stabilising antipsychotics\u2014due to 5-HT7 inhibition has not been observed with lurasidone and vortioxetine; however, several clinical studies suggest that 5-HT7 inhibition likely contributes to quality of life of patients with schizophrenia and mood disorders via the improvement of cognition. Furthermore, recent preclinical studies reported that 5-HT7 inhibition might mitigate antipsychotic-induced weight gain and metabolic complication by blocking other monoamine receptors. Further preclinical studies for the development of 5-HT7 modulation against neurodevelopmental disorders and neurodegenerative diseases have been ongoing. To date, various findings from various preclinical studies indicate the possibility that 5-HT7 modifications can provide two independent strategies. The first is that 5-HT7 inhibition ameliorates the dysfunction of inter-neuronal transmission in mature networks. The other is that activation of 5-HT7 can improve transmission dysfunction due to microstructure abnormality in the neurotransmission network\u2014which could be unaffected by conventional therapeutic agents\u2014via modulating intracellular signalling during the neurodevelopmental stage or via loss of neural networks with aging. This review attempts to describe the current and novel clinical applications of 5-HT7 modulation based on preclinical findings.<\/jats:p>","DOI":"10.3390\/ijms24032070","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T06:52:41Z","timestamp":1674197561000},"page":"2070","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2951-158X","authenticated-orcid":false,"given":"Kouji","family":"Fukuyama","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishi","family":"Motomura","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-2548","authenticated-orcid":false,"given":"Motohiro","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Division of Neuroscience, Graduate School of Medicine, Mie University, Tsu 514-8507, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"23422","DOI":"10.1016\/S0021-9258(19)49479-9","article-title":"Cloning of a novel human serotonin receptor (5-ht7) positively linked to adenylate cyclase","volume":"268","author":"Bard","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0896-6273(93)90149-L","article-title":"A novel adenylyl cyclase-activating serotonin receptor (5-ht7) implicated in the regulation of mammalian circadian rhythms","volume":"11","author":"Lovenberg","year":"1993","journal-title":"Neuron"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.1073\/pnas.90.18.8547","article-title":"Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-ht7) activating camp formation","volume":"90","author":"Ruat","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1016\/S0021-9258(17)46830-X","article-title":"Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype","volume":"268","author":"Shen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/acschemneuro.8b00283","article-title":"Pharmacology and therapeutic potential of the 5-ht7 receptor","volume":"10","author":"Blattner","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00221-013-3694-y","article-title":"The serotonin 5-ht 7 receptors: Two decades of research","volume":"230","author":"Gellynck","year":"2013","journal-title":"Exp. Brain Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s12035-011-8175-3","article-title":"Role of the 5-ht7 receptor in the central nervous system: From current status to future perspectives","volume":"43","author":"Matthys","year":"2011","journal-title":"Mol. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"107830","DOI":"10.1016\/j.neuropharm.2019.107830","article-title":"Towards selective cns pet imaging of the 5-ht7 receptor system: Past, present and future","volume":"172","author":"Erlandsson","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.neuropharm.2015.10.019","article-title":"The 5-ht7 receptor triggers cerebellar long-term synaptic depression via pkc-mapk","volume":"101","author":"Lippiello","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fnbeh.2014.00318","article-title":"The serotonin receptor 7 and the structural plasticity of brain circuits","volume":"8","author":"Volpicelli","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12576-012-0250-7","article-title":"Electrophysiological and pharmacological properties of gabaergic cells in the dorsal raphe nucleus","volume":"63","author":"Gocho","year":"2013","journal-title":"J. Physiol. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Okada, M., Fukuyama, K., Okubo, R., Shiroyama, T., and Ueda, Y. (2019). Lurasidone sub-chronically activates serotonergic transmission via desensitization of 5-ht1a and 5-ht7 receptors in dorsal raphe nucleus. Pharmaceuticals, 12.","DOI":"10.3390\/ph12040149"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/syn.21846","article-title":"Stimulation of 5-ht 7 receptor during adolescence determines its persistent upregulation in adult rat forebrain areas","volume":"69","author":"Nativio","year":"2015","journal-title":"Synapse"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/jsm.12131","article-title":"Brain regionspecific transcriptomic markers of serotonin1a receptor agonist action mediating sexual rejection and aggression in female marmoset monkeys","volume":"10","author":"Aubert","year":"2013","journal-title":"J. Sex. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nlm.2016.10.011","article-title":"Effects of 5-ht-7 receptor ligands on memory and cognition","volume":"136","author":"Zareifopoulos","year":"2016","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"623684","DOI":"10.3389\/fpsyt.2021.623684","article-title":"Current limitations and candidate potential of 5-ht7 receptor antagonism in psychiatric pharmacotherapy","volume":"12","author":"Okubo","year":"2021","journal-title":"Front. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neuroscience.2004.01.014","article-title":"Radioligand binding analysis of knockout mice reveals 5-hydroxytryptamine(7) receptor distribution and uncovers 8-hydroxy-2-(di-n-propylamino)tetralin interaction with alpha(2) adrenergic receptors","volume":"124","author":"Bonaventure","year":"2004","journal-title":"Neuroscience"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molonc.2015.09.008","article-title":"5-hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing beta-catenin","volume":"10","author":"Fatima","year":"2016","journal-title":"Mol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Tzirogiannis, K.N., Kourentzi, K.T., Zyga, S., Papalimneou, V., Tsironi, M., Grypioti, A.D., Protopsaltis, I., Panidis, D., and Panoutsopoulos, G.I. (2014). Effect of 5-ht7 receptor blockade on liver regeneration after 60\u201370% partial hepatectomy. BMC Gastroenterol., 14.","DOI":"10.1186\/s12876-014-0201-2"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/cas.12174","article-title":"Serotonin and the 5-ht7 receptor: The link between hepatocytes, igf-1 and small intestinal neuroendocrine tumors","volume":"104","author":"Svejda","year":"2013","journal-title":"Cancer Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12943-016-0559-6","article-title":"Tryptophan hydroxylase 1 and 5-ht(7) receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling","volume":"15","author":"Gautam","year":"2016","journal-title":"Mol. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.biopsych.2005.05.012","article-title":"5-ht7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern","volume":"58","author":"Hedlund","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","article-title":"Effect of the selective 5-ht7 receptor antagonist sb 269970 in animal models of anxiety and depression","volume":"51","author":"Wesolowska","year":"2006","journal-title":"Neuropharmacology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nlm.2016.12.017","article-title":"Modulation of the consolidation and reconsolidation of fear memory by three different serotonin receptors in hippocampus","volume":"142","author":"Schmidt","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1124\/jpet.111.180638","article-title":"The role of 5-hydroxytryptamine 7 receptors in the phencyclidine-induced novel object recognition deficit in rats","volume":"338","author":"Horiguchi","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.biopsych.2012.06.008","article-title":"Activation of 5-ht7 serotonin receptors reverses metabotropic glutamate receptor-mediated synaptic plasticity in wild-type and fmr1 knockout mice, a model of fragile x syndrome","volume":"72","author":"Costa","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-ht7) and 5-ht1a receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10578-013-0390-x","article-title":"A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial","volume":"45","author":"Ghanizadeh","year":"2014","journal-title":"Child Psychiatry Hum. Dev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1124\/jpet.114.213793","article-title":"Brexpiprazole i: In vitro and in vivo characterization of a novel serotonin-dopamine activity modulator","volume":"350","author":"Maeda","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1001\/archpsyc.1997.01830220102017","article-title":"D2 dopamine receptor occupancy: A crossover comparison of risperidone with clozapine therapy in schizophrenic patients","volume":"54","author":"Su","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/schbul\/17.2.263","article-title":"The mechanism of action of novel antipsychotic drugs","volume":"17","author":"Meltzer","year":"1991","journal-title":"Schizophr. Bull."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1021\/jm049632c","article-title":"Discovery of new tetracyclic tetrahydrofuran derivatives as potential broad-spectrum psychotropic agents","volume":"48","author":"Fernandez","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.critrevonc.2018.06.004","article-title":"Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma","volume":"128","author":"Elmaci","year":"2018","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_35","first-page":"102","article-title":"Active metabolites as antidepressant drugs: The role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders","volume":"4","author":"Alamo","year":"2013","journal-title":"Front. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1124\/mol.106.024612","article-title":"Risperidone irreversibly binds to and inactivates the h5-ht7 serotonin receptor","volume":"70","author":"Smith","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1021\/jm101459g","article-title":"Discovery of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine (lu aa21004): A novel multimodal compound for the treatment of major depressive disorder","volume":"54","author":"Ruhland","year":"2011","journal-title":"J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Okada, M., Okubo, R., and Fukuyama, K. (2019). Vortioxetine subchronically activates serotonergic transmission via desensitization of serotonin 5-ht1a receptor with 5-ht3 receptor inhibition in rats. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20246235"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1111\/bph.14804","article-title":"Lurasidone inhibits nmda\/glutamate antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-ht7 receptor blockade","volume":"176","author":"Okada","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Okada, M., Matsumoto, R., Yamamoto, Y., and Fukuyama, K. (2021). Effects of subchronic administrations of vortioxetine, lurasidone and escitalopram on thalamocortical glutamatergic transmission associated with serotonin 5-ht7 receptor. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031351"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112750","DOI":"10.1016\/j.biopha.2022.112750","article-title":"Impact of 5-ht7 receptor inverse agonism of lurasidone on monoaminergic tripartite synaptic transmission and pathophysiology of lower risk of weight gain","volume":"148","author":"Fukuyama","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Shiroyama, T., Fukuyama, K., and Okada, M. (2021). Distinct effects of escitalopram and vortioxetine on astroglial l-glutamate release associated with connexin43. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810013"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Lee, J., Avramets, D., Jeon, B., and Choo, H. (2021). Modulation of serotonin receptors in neurodevelopmental disorders: Focus on 5-ht7 receptor. Molecules, 26.","DOI":"10.3390\/molecules26113348"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-022-00497-2","article-title":"Central nervous system effects of 5-ht(7) receptors: A potential target for neurodegenerative diseases","volume":"28","year":"2022","journal-title":"Mol. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.celrep.2017.05.023","article-title":"Synaptic remodeling depends on signaling between serotonin receptors and the extracellular matrix","volume":"19","author":"Bijata","year":"2017","journal-title":"Cell Rep."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Okada, M., Fukuyama, K., and Motomura, E. (2022). Dose-dependent biphasic action of quetiapine on ampk signalling via 5-ht7 receptor: Exploring pathophysiology of clinical and adverse effects of quetiapine. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169103"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., Motomura, E., and Okada, M. (2022). Brexpiprazole reduces 5-ht7 receptor function on astroglial transmission systems. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126571"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/cne.1109","article-title":"Subcellular distribution of 5-ht1b and 5-ht7 receptors in the mouse suprachiasmatic nucleus","volume":"432","author":"Belenky","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1152\/physrev.1979.59.3.449","article-title":"Neural regulation of circadian rhythms","volume":"59","author":"Rusak","year":"1979","journal-title":"Physiol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejphar.2004.05.033","article-title":"Differential inverse agonist efficacies of sb-258719, sb-258741 and sb-269970 at human recombinant serotonin 5-ht7 receptors","volume":"495","author":"Mahe","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bjp.0703357","article-title":"Characterization of sb-269970-a, a selective 5-ht7 receptor antagonist","volume":"130","author":"Hagan","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/da.1043","article-title":"Depression, sleep physiology, and antidepressant drugs","volume":"14","author":"Winokur","year":"2001","journal-title":"Depress. Anxiety"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neuropharm.2004.11.015","article-title":"Genetic knockout and pharmacological blockade studies of the 5-ht7 receptor suggest therapeutic potential in depression","volume":"48","author":"Guscott","year":"2005","journal-title":"Neuropharmacology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1124\/jpet.107.119404","article-title":"Selective blockade of 5-hydroxytryptamine (5-ht)7 receptors enhances 5-ht transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents","volume":"321","author":"Bonaventure","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2006.10.001","article-title":"Enhancement of the anti-immobility action of antidepressants by a selective 5-ht7 receptor antagonist in the forced swimming test in mice","volume":"555","author":"Wesolowska","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"ref_58","first-page":"464","article-title":"Influence of serotonin 5-ht(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats","volume":"60","author":"Wesolowska","year":"2008","journal-title":"Pharmacol. Rep. PR"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/npp.2011.13","article-title":"Pharmacological blockade of 5-ht7 receptors as a putative fast acting antidepressant strategy","volume":"36","author":"Faure","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ejphar.2006.09.064","article-title":"Potential anxiolytic and antidepressant effects of the selective 5-ht7 receptor antagonist sb 269970 after intrahippocampal administration to rats","volume":"553","author":"Wesolowska","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neuroscience.2015.10.016","article-title":"Activation and blockade of serotonin7 receptors in the prelimbic cortex regulate depressive-like behaviors in a 6-hydroxydopamine-induced parkinson\u2019s disease rat model","volume":"311","author":"Zhang","year":"2015","journal-title":"Neuroscience"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.brainres.2016.05.016","article-title":"Serotonin7 receptors in the lateral habenular nucleus regulate depressive-like behaviors in the hemiparkinsonian rats","volume":"1644","author":"Han","year":"2016","journal-title":"Brain Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0304-3940(01)02054-7","article-title":"Acute restraint stress increases 5-ht7 receptor mrna expression in the rat hippocampus","volume":"309","author":"Yau","year":"2001","journal-title":"Neurosci. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1111\/j.1460-9568.2004.03288.x","article-title":"Mice lacking 5-ht receptors show specific impairments in contextual learning","volume":"19","author":"Roberts","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1046\/j.1471-4159.1998.71031271.x","article-title":"Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function","volume":"71","author":"Clemett","year":"1998","journal-title":"J. Neurochem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neulet.2006.12.054","article-title":"The 5-ht7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder","volume":"414","author":"Hedlund","year":"2007","journal-title":"Neurosci. Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopsych.2006.12.011","article-title":"Inactivation of the 5-ht(7) receptor partially blocks phencyclidine-induced disruption of prepulse inhibition","volume":"63","author":"Semenova","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2011.12.009","article-title":"Effects of the selective 5-ht(7) receptor antagonist sb-269970 in animal models of psychosis and cognition","volume":"228","author":"Waters","year":"2012","journal-title":"Behav. Brain Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/FBP.0b013e3282f62d8c","article-title":"Effects of sb-269970, a 5-ht7 receptor antagonist, in mouse models predictive of antipsychotic-like activity","volume":"19","author":"Galici","year":"2008","journal-title":"Behav. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Nikiforuk, A., Kos, T., Fijal, K., Holuj, M., Rafa, D., and Popik, P. (2013). Effects of the selective 5-ht7 receptor antagonist sb-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0066695"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1527-3458.2002.tb00217.x","article-title":"Sb-258741: A 5-ht7 receptor antagonist of potential clinical interest","volume":"8","author":"Pouzet","year":"2002","journal-title":"CNS Drug Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/hipo.20459","article-title":"Effects of 5-ht drugs in prefrontal cortex during memory formation and the ketamine amnesia-model","volume":"18","author":"Meneses","year":"2008","journal-title":"Hippocampus"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bbr.2004.04.026","article-title":"Effects of the 5-ht7 receptor antagonists sb-269970 and dr 4004 in autoshaping pavlovian\/instrumental learning task","volume":"155","author":"Meneses","year":"2004","journal-title":"Behav. Brain Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbr.2005.04.014","article-title":"Effects of the potential 5-ht7 receptor agonist as 19 in an autoshaping learning task","volume":"163","author":"Meneses","year":"2005","journal-title":"Behav. Brain Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2015.04.030","article-title":"Effects of the selective 5-ht7 receptor antagonist sb-269970 on premature responding in the five-choice serial reaction time test in rats","volume":"289","author":"Nikiforuk","year":"2015","journal-title":"Behav. Brain Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1176\/ps.2009.60.11.1439","article-title":"What did star*d teach us? Results from a large-scale, practical, clinical trial for patients with depression","volume":"60","author":"Gaynes","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nature10130","article-title":"Nmda receptor blockade at rest triggers rapid behavioural antidepressant responses","volume":"475","author":"Autry","year":"2011","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e1324","DOI":"10.4088\/JCP.15m10261","article-title":"Efficacy of lurasidone in adults aged 55 years and older with bipolar depression: Post hoc analysis of 2 double-blind, placebo-controlled studies","volume":"77","author":"Sajatovic","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1176\/appi.ajp.2015.15060770","article-title":"Lurasidone for the treatment of major depressive disorder with mixed features: A randomized, double-blind, placebo-controlled study","volume":"173","author":"Suppes","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1017\/S1092852917000074","article-title":"Lurasidone for major depressive disorder with mixed features and anxiety: A post-hoc analysis of a randomized, placebo-controlled study","volume":"22","author":"Tsai","year":"2017","journal-title":"CNS Spectr."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/15622975.2017.1285050","article-title":"Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis","volume":"19","author":"Ostacher","year":"2018","journal-title":"World J. Biol. Psychiatry Off. J. World Fed. Soc. Biol. Psychiatry"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/YIC.0000000000000271","article-title":"Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: A 2-week, randomized, double-blind, placebo-controlled study","volume":"34","author":"Vieta","year":"2019","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bcpt.12256","article-title":"Population pharmacokinetic meta-analysis of vortioxetine in healthy individuals","volume":"115","author":"Areberg","year":"2014","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v68n0713","article-title":"Clinical factors associated with treatment resistance in major depressive disorder: Results from a european multicenter study","volume":"68","author":"Souery","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: A star*d report","volume":"165","author":"Fava","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.2174\/1389450118666171117131151","article-title":"Vortioxetine treatment for anxiety disorder: A meta-analysis study","volume":"19","author":"Yee","year":"2018","journal-title":"Curr. Drug Targets"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jad.2016.07.015","article-title":"A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (mdd) and high levels of anxiety symptoms","volume":"206","author":"Baldwin","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2147\/NDT.S104050","article-title":"The efficacy and safety of multiple doses of vortioxetine for generalized anxiety disorder: A meta-analysis","volume":"12","author":"Fu","year":"2016","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e033161","DOI":"10.1136\/bmjopen-2019-033161","article-title":"Vortioxetine treatment for generalised anxiety disorder: A meta-analysis of anxiety, quality of life and safety outcomes","volume":"9","author":"Qin","year":"2019","journal-title":"BMJ Open"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"580858","DOI":"10.3389\/fphar.2020.580858","article-title":"Comparative remission rates and tolerability of drugs for generalised anxiety disorder: A systematic review and network meta-analysis of double-blind randomized controlled trials","volume":"11","author":"Kong","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e8172","DOI":"10.5867\/medwave.2021.03.8171","article-title":"Vortioxetine for generalised anxiety disorder in adults","volume":"21","author":"Meza","year":"2021","journal-title":"Medwave"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1017\/S1461145714000546","article-title":"A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults","volume":"17","author":"McIntyre","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/npp.2015.52","article-title":"A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder","volume":"40","author":"Mahableshwarkar","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4088\/JCP.16m10744","article-title":"Efficacy of vortioxetine on cognitive functioning in working patients with major depressive disorder","volume":"78","author":"McIntyre","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyx070","article-title":"A network meta-analysis comparing effects of various antidepressant classes on the digit symbol substitution test (dsst) as a measure of cognitive dysfunction in patients with major depressive disorder","volume":"21","author":"Baune","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"pyw054","DOI":"10.1093\/ijnp\/pyw054","article-title":"Which cognitive domains are improved by treatment with vortioxetine?","volume":"19","author":"Harrison","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1017\/S1092852919000786","article-title":"Long-term functioning outcomes are predicted by cognitive symptoms in working patients with major depressive disorder treated with vortioxetine: Results from the atworc study","volume":"24","author":"Chokka","year":"2019","journal-title":"CNS Spectr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: A systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.euroneuro.2018.03.008","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis","volume":"28","author":"Krause","year":"2018","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jpsychires.2021.04.032","article-title":"Efficacy and safety of antipsychotic treatments for schizophrenia: A systematic review and network meta-analysis of randomized trials in japan","volume":"138","author":"Kishi","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/YIC.0000000000000427","article-title":"Systematic literature review and network meta-analysis of lurasidone, brexpiprazole and cariprazine for schizophrenia","volume":"38","author":"Phalguni","year":"2023","journal-title":"Int. Clin. Psychopharmacol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: A systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1038\/s41380-020-00946-6","article-title":"Mood stabilizers and\/or antipsychotics for bipolar disorder in the maintenance phase: A systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Kishi","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar i depression: A randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","article-title":"Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar i depression: A randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/pcn.13137","article-title":"Double-blind, placebo-controlled study of lurasidone monotherapy for the treatment of bipolar i depression","volume":"74","author":"Kato","year":"2020","journal-title":"Psychiatry Clin. Neurosci."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaac.2017.10.006","article-title":"Efficacy and safety of lurasidone in children and adolescents with bipolar i depression: A double-blind, placebo-controlled study","volume":"56","author":"DelBello","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/JCP.0000000000001205","article-title":"Lurasidone improves psychopathology and cognition in treatment-resistant schizophrenia","volume":"40","author":"Meltzer","year":"2020","journal-title":"J. Clin. Psychopharmacol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/bdi.13193","article-title":"Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the international society for bipolar disorders targeting cognition task force","volume":"24","author":"Miskowiak","year":"2022","journal-title":"Bipolar. Disord."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1038\/s41598-021-84836-z","article-title":"A network meta-analysis of the dose-response effects of lurasidone on acute schizophrenia","volume":"11","author":"Srisurapanont","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","article-title":"Dose-response meta-analysis of antipsychotic drugs for acute schizophrenia","volume":"177","author":"Leucht","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jad.2019.11.031","article-title":"Efficacy and safety of lurasidone versus placebo as adjunctive to mood stabilizers in bipolar i depression: A meta-analysis","volume":"264","author":"Wang","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0028-3908(98)00070-7","article-title":"Function and distribution of three rat 5-hydroxytryptamine7 (5-ht7) receptor isoforms produced by alternative splicing","volume":"37","author":"Heidmann","year":"1998","journal-title":"Neuropharmacology"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1046\/j.1471-4159.1997.68041372.x","article-title":"Four 5-hydroxytryptamine7 (5-ht7) receptor isoforms in human and rat produced by alternative splicing: Species differences due to altered intron-exon organization","volume":"68","author":"Heidmann","year":"1997","journal-title":"J. Neurochem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s002100000369","article-title":"The cloned human 5-ht7 receptor splice variants: A comparative characterization of their pharmacology, function and distribution","volume":"363","author":"Krobert","year":"2001","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1111\/bph.13169","article-title":"The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-ht7 receptors","volume":"172","author":"Andressen","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1124\/jpet.104.081919","article-title":"Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms","volume":"313","author":"Guthrie","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"7821","DOI":"10.1523\/JNEUROSCI.1790-05.2005","article-title":"5-ht7 receptor is coupled to g alpha subunits of heterotrimeric g12-protein to regulate gene transcription and neuronal morphology","volume":"25","author":"Kvachnina","year":"2005","journal-title":"J. Neurosci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"17469","DOI":"10.1074\/jbc.273.28.17469","article-title":"Stimulation of type 1 and type 8 ca2+\/calmodulin-sensitive adenylyl cyclases by the gs-coupled 5-hydroxytryptamine subtype 5-ht7a receptor","volume":"273","author":"Baker","year":"1998","journal-title":"J Biol Chem"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1101\/lm.037101.114","article-title":"Epac activation initiates associative odor preference memories in the rat pup","volume":"22","author":"Grimes","year":"2015","journal-title":"Learn. Mem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1471-4159.2003.02076.x","article-title":"Coupling of neuronal 5-ht7 receptors to activation of extracellular-regulated kinase through a protein kinase a-independent pathway that can utilize epac","volume":"87","author":"Lin","year":"2003","journal-title":"J. Neurochem."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neuropharm.2012.10.026","article-title":"The serotonin receptor 7 promotes neurite outgrowth via erk and cdk5 signaling pathways","volume":"67","author":"Speranza","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fnmol.2018.00353","article-title":"Activation of serotonin 5-ht7 receptors modulates hippocampal synaptic plasticity by stimulation of adenylate cyclases and rescues learning and behavior in a mouse model of fragile x syndrome","volume":"11","author":"Costa","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.arr.2016.04.003","article-title":"Age-related changes in ampk activation: Role for ampk phosphatases and inhibitory phosphorylation by upstream signaling pathways","volume":"28","author":"Salminen","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1152\/jn.00374.2015","article-title":"Spinal 5-ht7 receptors induce phrenic motor facilitation via epac-mtorc1 signaling","volume":"114","author":"Fields","year":"2015","journal-title":"J. Neurophysiol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"8001","DOI":"10.1007\/s00018-021-04004-4","article-title":"Autophagy and apoptosis cascade: Which is more prominent in neuronal death?","volume":"78","author":"Gupta","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fnbeh.2015.00062","article-title":"Activation of 5-ht7 receptor stimulates neurite elongation through mtor, cdc42 and actin filaments dynamics","volume":"9","author":"Speranza","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12035-007-0023-0","article-title":"Morphogenic signaling in neurons via neurotransmitter receptors and small gtpases","volume":"35","author":"Ponimaskin","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pneurobio.2016.03.007","article-title":"How serotonin receptors regulate morphogenic signalling in neurons","volume":"151","author":"Wirth","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Crispino, M., Volpicelli, F., and Perrone-Capano, C. (2020). Role of the serotonin receptor 7 in brain plasticity: From development to disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21020505"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.neuron.2008.02.031","article-title":"Rapid synaptic scaling induced by changes in postsynaptic firing","volume":"57","author":"Ibata","year":"2008","journal-title":"Neuron"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.npp.1301559","article-title":"Synaptic plasticity: Multiple forms, functions, and mechanisms","volume":"33","author":"Citri","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cell.2014.10.035","article-title":"Neuronal plasticity: Beyond the critical period","volume":"159","author":"Bonhoeffer","year":"2014","journal-title":"Cell"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1523\/JNEUROSCI.2765-11.2012","article-title":"5-ht7r\/g12 signaling regulates neuronal morphology and function in an age-dependent manner","volume":"32","author":"Kobe","year":"2012","journal-title":"J. Neurosci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbr.2016.12.006","article-title":"Deletion of the serotonin receptor type 7 disrupts the acquisition of allocentric but not egocentric navigation strategies in mice","volume":"320","author":"Beaudet","year":"2017","journal-title":"Behav. Brain Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-6606-6-24","article-title":"Acute 5-ht7 receptor activation increases nmda-evoked currents and differentially alters nmda receptor subunit phosphorylation and trafficking in hippocampal neurons","volume":"6","author":"Vasefi","year":"2013","journal-title":"Mol. Brain"},{"key":"ref_137","first-page":"672","article-title":"5-hydroxytryptamine(7) receptor activation decreases slow afterhyperpolarization amplitude in ca3 hippocampal pyramidal cells","volume":"294","author":"Bacon","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.brainres.2003.09.015","article-title":"5-ht7 receptors increase the excitability of rat hippocampal ca1 pyramidal neurons","volume":"993","author":"Tokarski","year":"2003","journal-title":"Brain Res"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/hipo.20940","article-title":"5-ht(1a) and 5-ht(7) receptors differently modulate ampa receptor-mediated hippocampal synaptic transmission","volume":"22","author":"Costa","year":"2012","journal-title":"Hippocampus"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1111\/bph.13432","article-title":"Hippocampal 5-ht7 receptors signal phosphorylation of the glua1 subunit to facilitate ampa receptor mediated-neurotransmission in vitro and in vivo","volume":"173","author":"Andreetta","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1601-183X.2009.00486.x","article-title":"Methylphenidate to adolescent rats drives enduring changes of accumbal htr7 expression: Implications for impulsive behavior and neuronal morphology","volume":"8","author":"Leo","year":"2009","journal-title":"Genes Brain Behav."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1523\/JNEUROSCI.3973-07.2008","article-title":"Inhibition of serotonin but not norepinephrine transport during development produces delayed, persistent perturbations of emotional behaviors in mice","volume":"28","author":"Ansorge","year":"2008","journal-title":"J. Neurosci."},{"key":"ref_143","first-page":"448","article-title":"Spatial memory deficit across aging: Current insights of the role of 5-ht7 receptors","volume":"8","author":"Beaudet","year":"2014","journal-title":"Front. Behav. Neurosci."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/j.bbadis.2013.08.012","article-title":"Structural plasticity of dendritic spines: The underlying mechanisms and its dysregulation in brain disorders","volume":"1832","author":"Lai","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.neuron.2017.04.041","article-title":"Camkii autophosphorylation is necessary for optimal integration of Ca2+ signals during ltp induction, but not maintenance","volume":"94","author":"Chang","year":"2017","journal-title":"Neuron"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.conb.2011.09.002","article-title":"Structural plasticity of dendritic spines","volume":"22","author":"Bosch","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"116049","DOI":"10.1016\/j.trac.2020.116049","article-title":"Evaluation of electrochemical methods for tonic dopamine detection in vivo","volume":"132","author":"Rusheen","year":"2020","journal-title":"Trends Analyt. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"110070","DOI":"10.1016\/j.biopha.2020.110070","article-title":"Pathomechanism of nocturnal paroxysmal dystonia in autosomal dominant sleep-related hypermotor epilepsy with s284l-mutant alpha4 subunit of nicotinic ach receptor","volume":"126","author":"Fukuyama","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., Nakano, T., Shiroyama, T., and Okada, M. (2021). Chronic administrations of guanfacine on mesocortical catecholaminergic and thalamocortical glutamatergic transmissions. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22084122"},{"key":"ref_150","unstructured":"Meltzer, H.Y. (2012). Handbook of Experimental Pharmacology, Springer."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00213-009-1601-9","article-title":"Effects of quetiapine on monoamine, gaba, and glutamate release in rat prefrontal cortex","volume":"206","author":"Yamamura","year":"2009","journal-title":"Psychopharmacology"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1476-5381.2009.00175.x","article-title":"Effects of zotepine on extracellular levels of monoamine, gaba and glutamate in rat prefrontal cortex","volume":"157","author":"Yamamura","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.11.023","article-title":"Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex","volume":"653","author":"Ohoyama","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.neuropharm.2011.08.031","article-title":"Dopamine d2 and serotonin 5-ht1a receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission","volume":"62","author":"Tanahashi","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cercor\/4.1.69","article-title":"The effects of haloperidol and clozapine on extracellular gaba levels in the prefrontal cortex of the rat: An in vivo microdialysis study","volume":"4","author":"Bourdelais","year":"1994","journal-title":"Cereb. Cortex"},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., Hasegawa, T., and Okada, M. (2018). Cystine\/glutamate antiporter and aripiprazole compensate nmda antagonist-induced dysfunction of thalamocortical l-glutamatergic transmission. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113645"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., Kato, R., Murata, M., Shiroyama, T., and Okada, M. (2019). Clozapine normalizes a glutamatergic transmission abnormality induced by an impaired nmda receptor in the thalamocortical pathway via the activation of a group iii metabotropic glutamate receptor. Biomolecules, 9.","DOI":"10.3390\/biom9060234"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Nakano, T., Hasegawa, T., Suzuki, D., Motomura, E., and Okada, M. (2019). Amantadine combines astroglial system xc(-) activation with glutamate\/nmda receptor inhibition. Biomolecules, 9.","DOI":"10.3390\/biom9050191"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"e00457","DOI":"10.1002\/prp2.457","article-title":"Memantine protects thalamocortical hyper-glutamatergic transmission induced by nmda receptor antagonism via activation of system xc()","volume":"7","author":"Okada","year":"2019","journal-title":"Pharmacol. Res. Perspect."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Okada, M., Fukuyama, K., Nakano, T., and Ueda, Y. (2019). Pharmacological discrimination of effects of mk801 on thalamocortical, mesothalamic, and mesocortical transmissions. Biomolecules, 9.","DOI":"10.3390\/biom9110746"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., Fukuzawa, M., and Okada, M. (2020). Upregulated and hyperactivated thalamic connexin 43 plays important roles in pathomechanisms of cognitive impairment and seizure of autosomal dominant sleep-related hypermotor epilepsy with s284l-mutant alpha4 subunit of nicotinic ach receptor. Pharmaceuticals, 13.","DOI":"10.3390\/ph13050099"},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., Fukuzawa, M., Okubo, R., and Okada, M. (2020). Upregulated connexin 43 induced by loss-of-functional s284l-mutant alpha4 subunit of nicotinic ach receptor contributes to pathomechanisms of autosomal dominant sleep-related hypermotor epilepsy. Pharmaceuticals, 13.","DOI":"10.3390\/ph13040058"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1111\/bph.14974","article-title":"Pathogenesis and pathophysiology of autosomal dominant sleep-related hypermotor epilepsy with s284l-mutant alpha4 subunit of nicotinic ach receptor","volume":"177","author":"Fukuyama","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"107547","DOI":"10.1016\/j.neuropharm.2019.02.029","article-title":"Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex","volume":"156","author":"Okada","year":"2019","journal-title":"Neuropharmacology"},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Okada, M., and Fukuyama, K. (2020). Interaction between mesocortical and mesothalamic catecholaminergic transmissions associated with nmda receptor in the locus coeruleus. Biomolecules, 10.","DOI":"10.3390\/biom10070990"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e69480","DOI":"10.7554\/eLife.69480","article-title":"Neuropsychological evidence of multi-domain network hubs in the human thalamus","volume":"10","author":"Hwang","year":"2021","journal-title":"eLife"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e81282","DOI":"10.7554\/eLife.81282","article-title":"Thalamocortical contributions to cognitive task activity","volume":"11","author":"Hwang","year":"2022","journal-title":"eLife"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e2018784118","DOI":"10.1073\/pnas.2018784118","article-title":"Cognitive impairment after focal brain lesions is better predicted by damage to structural than functional network hubs","volume":"118","author":"Reber","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"112846","DOI":"10.1016\/j.biopha.2022.112846","article-title":"High frequency oscillations play important roles in development of epileptogenesis\/ictogenesis via activation of astroglial signallings","volume":"149","author":"Fukuyama","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1152\/physrev.00042.2018","article-title":"Sleep spindles: Mechanisms and functions","volume":"100","author":"Fernandez","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., and Okada, M. (2022). Brivaracetam and levetiracetam suppress astroglial l-glutamate release through hemichannel via inhibition of synaptic vesicle protein. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23094473"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1523\/JNEUROSCI.2107-18.2018","article-title":"Occurrence of hippocampal ripples is associated with activity suppression in the mediodorsal thalamic nucleus","volume":"39","author":"Yang","year":"2019","journal-title":"J. Neurosci."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1111\/bph.15443","article-title":"Can rodent models elucidate the pathomechanisms of genetic epilepsy?","volume":"179","author":"Okada","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Okada, M., Kawano, Y., Fukuyama, K., Motomura, E., and Shiroyama, T. (2020). Candidate strategies for development of a rapid-acting antidepressant class without neuropsychiatric adverse effects: Prevention of ketamine-induced neuropsychiatric adverse reactions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217951"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Okada, M., Fukuyama, K., Shiroyama, T., and Murata, M. (2020). A working hypothesis regarding identical pathomechanisms between clinical efficacy and adverse reaction of clozapine via the activation of connexin43. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21197019"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.neubiorev.2014.01.006","article-title":"Fragile x syndrome: From molecular pathology to therapy","volume":"46","author":"Maurin","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1523\/JNEUROSCI.3888-10.2010","article-title":"Hypersensitivity to mglur5 and erk1\/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile x syndrome","volume":"30","author":"Osterweil","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.1073\/pnas.122205699","article-title":"Altered synaptic plasticity in a mouse model of fragile x mental retardation","volume":"99","author":"Huber","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Kelley, D.J., Davidson, R.J., Elliott, J.L., Lahvis, G.P., Yin, J.C., and Bhattacharyya, A. (2007). The cyclic amp cascade is altered in the fragile x nervous system. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0000931"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"e000717","DOI":"10.1136\/bmjpo-2020-000717","article-title":"Consensus guidelines on managing rett syndrome across the lifespan","volume":"4","author":"Fu","year":"2020","journal-title":"BMJ Paediatr. Open"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/01.wnl.0000291011.54508.aa","article-title":"Specific mutations in methyl-cpg-binding protein 2 confer different severity in rett syndrome","volume":"70","author":"Neul","year":"2008","journal-title":"Neurology"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e227","DOI":"10.1212\/NXG.0000000000000227","article-title":"Wdr45 mutations may cause a mecp2 mutation-negative rett syndrome phenotype","volume":"4","author":"Kulikovskaja","year":"2018","journal-title":"Neurol. Genet."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1093\/hmg\/ddh282","article-title":"Mild overexpression of mecp2 causes a progressive neurological disorder in mice","volume":"13","author":"Collins","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/npp.2014.105","article-title":"Pharmacological stimulation of the brain serotonin receptor 7 as a novel therapeutic approach for rett syndrome","volume":"39","author":"Nativio","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"ref_185","first-page":"86","article-title":"Long-lasting beneficial effects of central serotonin receptor 7 stimulation in female mice modeling rett syndrome","volume":"9","author":"Chiodi","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/(SICI)1096-8628(19991015)88:5<472::AID-AJMG7>3.0.CO;2-G","article-title":"Physical mapping of the serotonin 5-ht(7) receptor gene (htr7) to chromosome 10 and pseudogene (htr7p) to chromosome 12, and testing of linkage disequilibrium between htr7 and autistic disorder","volume":"88","author":"Lassig","year":"1999","journal-title":"Am. J. Med. Genet."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2217\/phe.10.45","article-title":"Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years","volume":"4","author":"Blankenship","year":"2010","journal-title":"Ped Health"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1124\/mol.108.052084","article-title":"Pharmacological analysis of the novel, rapid, and potent inactivation of the human 5-hydroxytryptamine7 receptor by risperidone, 9-oh-risperidone, and other inactivating antagonists","volume":"75","author":"Knight","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10803-015-2628-x","article-title":"Lurasidone for the treatment of irritability associated with autistic disorder","volume":"46","author":"Loebel","year":"2016","journal-title":"J. Autism. Dev. Disord."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2165\/00003495-200666160-00004","article-title":"Disease-modifying therapies in alzheimer\u2019s disease: How far have we come?","volume":"66","author":"Hull","year":"2006","journal-title":"Drugs"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4155\/fmc-2017-0031","article-title":"Modulating 5-ht(4) and 5-ht(6) receptors in alzheimer\u2019s disease treatment","volume":"9","author":"Lalut","year":"2017","journal-title":"Future Med. Chem."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.brainresbull.2017.10.004","article-title":"The effects of the 5-ht7 receptor on hippocampal long-term potentiation and apoptosis in a rat model of alzheimer\u2019s disease","volume":"135","author":"Komaki","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer\u2019s disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"P1.1-005","DOI":"10.1212\/WNL.92.15_supplement.P1.1-005","article-title":"Procognitive and neuroprotective effect of 5-ht7 agonist in an animal model by icv amyloid-b injection (p1.1-005)","volume":"92","author":"Villegas","year":"2019","journal-title":"Neurology"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1148\/rg.2016150172","article-title":"Multimodality review of amyloid-related diseases of the central nervous system","volume":"36","author":"Sipe","year":"2016","journal-title":"Radiographics"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/FBP.0000000000000279","article-title":"Neural activity, memory, and dementias: Serotonergic markers","volume":"28","author":"Meneses","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2174\/1381612822666160127113524","article-title":"Serotonergic drugs: Agonists\/antagonists at specific serotonergic subreceptors for the treatment of cognitive, depressant and psychotic symptoms in alzheimer\u2019s disease","volume":"22","author":"Werner","year":"2016","journal-title":"Curr. Pharm. Des."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/PL00005123","article-title":"Correlation between 5-ht7 receptor affinity and protection against sound-induced seizures in dba\/2j mice","volume":"356","author":"Bourson","year":"1997","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2004.01.072","article-title":"Selective 5-ht1a and 5-ht7 antagonists decrease epileptic activity in the wag\/rij rat model of absence epilepsy","volume":"359","author":"Graf","year":"2004","journal-title":"Neurosci. Lett."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2012.04.011","article-title":"Involvement of 5-ht(7) receptors in the pathogenesis of temporal lobe epilepsy","volume":"685","author":"Yang","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.eplepsyres.2007.03.017","article-title":"Constitutive deletion of the serotonin-7 (5-ht(7)) receptor decreases electrical and chemical seizure thresholds","volume":"75","author":"Witkin","year":"2007","journal-title":"Epilepsy Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"R81","DOI":"10.1186\/bcr2448","article-title":"Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival","volume":"11","author":"Pai","year":"2009","journal-title":"Breast Cancer Res."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"f2539","DOI":"10.1136\/bmj.f2539","article-title":"The gap in life expectancy from preventable physical illness in psychiatric patients in western australia: Retrospective analysis of population based registers","volume":"346","author":"Lawrence","year":"2013","journal-title":"BMJ"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/j.2051-5545.2011.tb00014.x","article-title":"Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care","volume":"10","author":"Correll","year":"2011","journal-title":"World Psychiatry"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1073\/pnas.0611417104","article-title":"From the cover: Antipsychotic drug-induced weight gain mediated by histamine h1 receptor-linked activation of hypothalamic amp-kinase","volume":"104","author":"Kim","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.tips.2022.04.007","article-title":"Hypothalamic ampk as a possible target for energy balance-related diseases","volume":"43","author":"Lopez","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: From mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuroscience.2005.03.045","article-title":"Biphasic actions of topiramate on monoamine exocytosis associated with both soluble n-ethylmaleimide-sensitive factor attachment protein receptors and ca(2+)-induced ca(2+)-releasing systems","volume":"134","author":"Okada","year":"2005","journal-title":"Neuroscience"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.neuropharm.2007.02.009","article-title":"Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor","volume":"52","author":"Yoshida","year":"2007","journal-title":"Neuropharmacology"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.neulet.2012.03.056","article-title":"Levetiracetam inhibits neurotransmitter release associated with cicr","volume":"518","author":"Fukuyama","year":"2012","journal-title":"Neurosci. Lett."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/emboj.2010.177","article-title":"An intimate liaison: Spatial organization of the endoplasmic reticulum-mitochondria relationship","volume":"29","author":"Scorrano","year":"2010","journal-title":"EMBO J."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.06.010","article-title":"Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, npy and ampk pathways","volume":"48","author":"Lian","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Fukuyama, K., and Okada, M. (2021). Effects of an atypical antipsychotic, zotepine, on astroglial l-glutamate release through hemichannels: Exploring the mechanism of mood-stabilising antipsychotic actions and antipsychotic-induced convulsion. Pharmaceuticals, 14.","DOI":"10.3390\/ph14111116"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2070\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:11:49Z","timestamp":1760119909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/3\/2070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,20]]},"references-count":213,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["ijms24032070"],"URL":"https:\/\/doi.org\/10.3390\/ijms24032070","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,20]]}}}